IL33 and neoplasm: On the other hand, in a mouse model for metastatic lung tumor, systemic administration of IL-33 induced the expansion of IL-5-producing ILC2s, which recruited and sustained eosinophils, critically contributing to increased tumor cell death, and thus preventing metastasis [152].